Compare · INDI vs INTC
INDI vs INTC
Side-by-side comparison of indie Semiconductor Inc. (INDI) and Intel Corporation (INTC): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both INDI and INTC operate in Semiconductors (Technology), so they compete in similar markets.
- INTC is the larger of the two at $518.28B, about 554.4x INDI ($934.8M).
- Over the past year, INDI is up 7.0% and INTC is up 342.0% - INTC leads by 335.0 points.
- INDI has been more active in the news (9 items in the past 4 weeks vs 3 for INTC).
- INTC has more recent analyst coverage (25 ratings vs 12 for INDI).
- Company
- indie Semiconductor Inc.
- Intel Corporation
- Price
- $4.12-7.21%
- $103.02-6.22%
- Market cap
- $934.8M
- $518.28B
- 1M return
- +4.83%
- -3.70%
- 1Y return
- +7.01%
- +342.00%
- Industry
- Semiconductors
- Semiconductors
- Exchange
- NASDAQ
- NASDAQ
- IPO
- News (4w)
- 9
- 3
- Recent ratings
- 12
- 25
Intel Corporation
Intel Corporation designs, manufactures, and sells essential technologies for the cloud, smart, and connected devices for retail, industrial, and consumer uses worldwide. The company operates through DCG, IOTG, Mobileye, NSG, PSG, CCG, and All Other segments. It offers platform products, such as central processing units and chipsets, and system-on-chip and multichip packages; and non-platform or adjacent products comprising accelerators, boards and systems, connectivity products, and memory and storage products. The company also provides Internet of Things products, including high-performance compute solutions for targeted verticals and embedded applications; and computer vision and machine learning-based sensing, data analysis, localization, mapping, and driving policy technology. It serves original equipment manufacturers, original design manufacturers, and cloud service providers. Intel Corporation has a strategic partnership with MILA to develop and apply advances in artificial intelligence methods for enhancing the search in the space of drugs. The company was founded in 1968 and is headquartered in Santa Clara, California.
Latest INDI
- Chief Operating Officer Wittmann Michael sold $29,214 worth of shares (6,250 units at $4.67) as part of a pre-agreed trading plan, decreasing direct ownership by 4% to 139,352 units (SEC Form 4) (withholding tax)
- indie Sets Date for Second Quarter 2026 Earnings Release and Conference Call
- Chief Operating Officer Wittmann Michael converted options into 77,500 shares and sold $134,460 worth of shares (30,207 units at $4.45), increasing direct ownership by 48% to 145,602 units (SEC Form 4) to satisfy withholding obligation
- Chief Financial Officer Wu Naixi converted options into 39,278 shares and sold $85,913 worth of shares (19,640 units at $4.37) as part of a pre-agreed trading plan, increasing direct ownership by 17% to 134,425 units (SEC Form 4) to cover taxes
- Director Schiller Thomas converted options into 5,000 shares and sold $8,159 worth of shares (1,833 units at $4.45), increasing direct ownership by 0.66% to 481,707 units (SEC Form 4) to satisfy withholding obligation
- Chief Executive Officer Mcclymont Donald converted options into 243,750 shares and sold $563,072 worth of shares (126,496 units at $4.45), increasing direct ownership by 38% to 424,617 units (SEC Form 4) (tax withholding)
- New insider Schiller Thomas claimed ownership of 478,540 shares (SEC Form 3)
- indie Semiconductor Inc. filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits
- indie Announces Changes to Board of Directors
- Chief Executive Officer Mcclymont Donald converted options into 50,000 shares and sold $209,255 worth of shares (50,000 units at $4.19) as part of a pre-agreed trading plan, decreasing direct ownership by 94% to 307,363 units (SEC Form 4)
Latest INTC
- Mobileye Announces Timing of its Second Quarter 2026 Results
- Intel to Report Second-Quarter 2026 Financial Results
- Goldman initiated coverage on Intel with a new price target
- Greenstone Biosciences, Inc. and Intel Corp. Launch Strategic Collaboration to Scale Human-Centric Drug Discovery
- IQM Appoints Craig Ciesla, Former Illumina VP, as CTO; Inés de Vega Becomes Chief Scientist
- Intel Announces Leadership Appointment at Intel Foundry to Accelerate Development and Manufacturing
- Intel Foundry Details Process Milestones and Future Innovation at VLSI Symposium
- Mobileye To Establish Vertically Integrated Robotaxi Business
- AI Infrastructure Boom Drives Demand for Semiconductor, Pharmaceutical Automation
- SEC Form 11-K filed by Intel Corporation